Valuation: BPH GLOBNPV

Market Cap 3.53M 2.47M 2.17M 2.06M 1.86M 3.5M 237M 24.64M 9.5M 121M 9.26M 9.06M 388M P/E 2024
-0.35x
P/E 2025 -0.75x
Enterprise Value 3.38M 2.36M 2.08M 1.97M 1.78M 3.34M 226M 23.58M 9.09M 116M 8.86M 8.67M 371M EV / Sales 2024
11.9x
EV / Sales 2025 5.53x
Free-Float
69.73%
Yield 2024 *
-
Yield 2025 -
1 day-7.69%
Current month+20.00%
1 month-20.00%
3 months-20.00%
6 months-40.00%
Current year-40.00%
1 week 0.01
Extreme 0.012
0.01
1 month 0.01
Extreme 0.01
0.02
Current year 0.01
Extreme 0.01
0.03
1 year 0.01
Extreme 0.01
0.03
3 years 0.01
Extreme 0.01
0.1
5 years 0.01
Extreme 0.01
0.3
10 years 0.01
Extreme 0.01
54.25
Manager TitleAgeSince
Chief Executive Officer 55 21/11/2023
Chief Tech/Sci/R&D Officer - 25/05/2026
Corporate Secretary - 11/04/2024
Director TitleAgeSince
Chairman - 22/06/2026
Director/Board Member 55 30/03/2023
Director/Board Member - 22/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
-7.69%0.00%-40.00%-88.00% 2.15M
-0.03%+6.41%+11.83%+38.36% 49.06B
-0.73%-0.33%+49.81%+36.06% 44.6B
+1.36%+6.08%+365.57%+624.08% 43.24B
-0.47%-0.04%+12.10%+98.46% 41.73B
+0.34%-1.38%+5.53%+47.36% 29.93B
+1.00%-0.33%+25.23%+152.51% 17.19B
-2.94%+5.83%+5.22% - 15.35B
-3.20%-2.38%+25.00%+43.67% 15.54B
-0.86%-4.01% - - 15.11B
Average -1.32%+2.12%+51.14%+119.06% 27.18B
Weighted average by Cap. -0.27%+2.42%+78.64%+162.88%

Financials

2024 2025
Net sales 110K 76.8K 67.72K 64.06K 58.02K 109K 7.37M 768K 296K 3.77M 288K 282K 12.08M 352K 246K 217K 205K 186K 349K 23.63M 2.46M 948K 12.08M 924K 904K 38.72M
Net income -2.65M -1.85M -1.63M -1.54M -1.4M -2.63M -178M -18.51M -7.13M -90.88M -6.96M -6.8M -291M -1.49M -1.04M -915K -866K -784K -1.47M -99.68M -10.38M -4M -50.94M -3.9M -3.81M -163M
Net Debt 119K 83.46K 73.59K 69.61K 63.05K 118K 8.01M 834K 321K 4.1M 313K 307K 13.13M -153K -107K -94.06K -88.98K -80.59K -151K -10.24M -1.07M -411K -5.23M -401K -392K -16.78M
Logo BPH GLOBNPV
Ocean Sciences Ltd, formerly BPH Global Limited, is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company's product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
Employees
31
Date Price Change Volume
29/09/26 A$0.0120 -7.69% 177,618
25/09/26 A$0.0130 +8.33% 54,933
22/09/26 A$0.0120 0.00% 0